Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Enterprise Value

Gilead Sciences Inc Enterprise Value Chart (GILD)

Gilead Sciences Inc annual/quarterly Enterprise Value from 2010 to 2020.
  • Gilead Sciences Inc Enterprise Value for the quarter ending November 11, 2020 was $77,806m a -0.61% decrease of -476m year over year
  • Gilead Sciences Inc Enterprise Value for the last 12 months ending November 11, 2020 was $77,806m a -0.61% decrease of -476m year over year
  • Gilead Sciences Inc Annual Enterprise Value for 2020 was $77,806m a 0.58% increase of 451m from 2019
  • Gilead Sciences Inc Annual Enterprise Value for 2020 was $77,355m a -0.36% decrease of -276m from 2019
  • Gilead Sciences Inc Annual Enterprise Value for 2020 was $77,631m a -0.84% decrease of -652m from 2019
Other Valuation Metrics:
  • Gilead Sciences Inc Market Cap for the quarter ending June 06, 2018 was $92,110m a -14.87% decrease of -13,696m year over year
  • Gilead Sciences Inc Price / Book for the quarter ending June 06, 2018 was 4.47 a -4.33% decrease of -0.19 year over year
View Chart On Koyfin

Quarterly GILD Enterprise Value Data

11/2020$77,806m
11/2020$77,355m
11/2020$77,631m
11/2020$78,282m
11/2020$78,621m
11/2020$78,709m
11/2020$78,859m
11/2020$78,226m
11/2020$77,468m
11/2020$77,618m

Annual GILD Enterprise Value Data

2020$77,806m
2020$77,355m
2020$77,631m
2020$78,282m
2020$78,621m
2020$78,709m
2020$78,859m
2020$78,226m
2020$77,468m
2020$77,618m